BCT 1902 (Neo-N): A phase II trial evaluating the efficacy of nivolumab or nivolumab plus relatlimab with paclitaxel and carboplatin as neoadjuvant therapy in early stage triple negative breast cancers
ACTRN 12619001308189 Brief Summary This study aims to find out how well…
Read more arrow_forward